In psychosis, cortical interneurons overexpress DNA-methyltransferase 1

Marin D Veldic, Alessandro Guidotti, Ekrem Maloku, John M. Davis, Erminio Costa

Research output: Contribution to journalArticle

216 Citations (Scopus)

Abstract

Cortical DNA-methyltransferase 1 (DNMT1) is preferentially expressed in interneurons secreting GABA where it very likely contributes to promoter CpG island hypermethylation, thus causing a down-regulation of promoter functions. To consolidate and expand on previous findings that, in the cortex of schizophrenia (SZ) brains, glutamic acid decarboxylase 67 (GAD67) expression is down-regulated whereas that of DNMT1 is up-regulated, we studied both parameters in Brodmann's area (BA) 9 from the McLean 66 Cohort Collection (Harvard Brain Tissue Resource Center, Belmont, MA). In BA9 of SZ and bipolar disorder patients with psychosis, DNMT1 mRNA and protein expression preferentially increases in layer I, II, and IV interneurons, and this increase is paralleled by a decreased number of GAD67 mRNA-positive neurons. The increase in DNMT1 and the decrease in GAD67-expressing neurons were unrelated to postmortem interval, pH, RNA quality, or to the presence, dose, or duration of antipsychotic (APS) medication, with the exception of a subgroup of SZ patients treated with a combination of valproate and APS in which the expression of DNMT1 failed to change. The DNMT1 increase and the GAD 67 decrease in BA9 interneurons are significant features of SZ and bipolar disorder with psychosis. Interestingly, the DNMT1 increase failed to occur when patients with psychosis received a combination of valproate and APS treatment but not APS monotherapy.

Original languageEnglish (US)
Pages (from-to)2152-2157
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number6
DOIs
StatePublished - Feb 8 2005
Externally publishedYes

Fingerprint

Methyltransferases
Interneurons
Psychotic Disorders
DNA
Antipsychotic Agents
Glutamate Decarboxylase
Schizophrenia
Valproic Acid
Bipolar Disorder
Neurons
Messenger RNA
CpG Islands
Brain
gamma-Aminobutyric Acid
Down-Regulation
RNA
Proteins

Keywords

  • Antipsychotics
  • Bipolar disorder
  • Glutamic acid decarboxylase
  • Schizophrenia
  • Valproate

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. / Veldic, Marin D; Guidotti, Alessandro; Maloku, Ekrem; Davis, John M.; Costa, Erminio.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 6, 08.02.2005, p. 2152-2157.

Research output: Contribution to journalArticle

Veldic, Marin D ; Guidotti, Alessandro ; Maloku, Ekrem ; Davis, John M. ; Costa, Erminio. / In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 6. pp. 2152-2157.
@article{0cd5d39a78714aab9fc5446269d9a83d,
title = "In psychosis, cortical interneurons overexpress DNA-methyltransferase 1",
abstract = "Cortical DNA-methyltransferase 1 (DNMT1) is preferentially expressed in interneurons secreting GABA where it very likely contributes to promoter CpG island hypermethylation, thus causing a down-regulation of promoter functions. To consolidate and expand on previous findings that, in the cortex of schizophrenia (SZ) brains, glutamic acid decarboxylase 67 (GAD67) expression is down-regulated whereas that of DNMT1 is up-regulated, we studied both parameters in Brodmann's area (BA) 9 from the McLean 66 Cohort Collection (Harvard Brain Tissue Resource Center, Belmont, MA). In BA9 of SZ and bipolar disorder patients with psychosis, DNMT1 mRNA and protein expression preferentially increases in layer I, II, and IV interneurons, and this increase is paralleled by a decreased number of GAD67 mRNA-positive neurons. The increase in DNMT1 and the decrease in GAD67-expressing neurons were unrelated to postmortem interval, pH, RNA quality, or to the presence, dose, or duration of antipsychotic (APS) medication, with the exception of a subgroup of SZ patients treated with a combination of valproate and APS in which the expression of DNMT1 failed to change. The DNMT1 increase and the GAD 67 decrease in BA9 interneurons are significant features of SZ and bipolar disorder with psychosis. Interestingly, the DNMT1 increase failed to occur when patients with psychosis received a combination of valproate and APS treatment but not APS monotherapy.",
keywords = "Antipsychotics, Bipolar disorder, Glutamic acid decarboxylase, Schizophrenia, Valproate",
author = "Veldic, {Marin D} and Alessandro Guidotti and Ekrem Maloku and Davis, {John M.} and Erminio Costa",
year = "2005",
month = "2",
day = "8",
doi = "10.1073/pnas.0409665102",
language = "English (US)",
volume = "102",
pages = "2152--2157",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - In psychosis, cortical interneurons overexpress DNA-methyltransferase 1

AU - Veldic, Marin D

AU - Guidotti, Alessandro

AU - Maloku, Ekrem

AU - Davis, John M.

AU - Costa, Erminio

PY - 2005/2/8

Y1 - 2005/2/8

N2 - Cortical DNA-methyltransferase 1 (DNMT1) is preferentially expressed in interneurons secreting GABA where it very likely contributes to promoter CpG island hypermethylation, thus causing a down-regulation of promoter functions. To consolidate and expand on previous findings that, in the cortex of schizophrenia (SZ) brains, glutamic acid decarboxylase 67 (GAD67) expression is down-regulated whereas that of DNMT1 is up-regulated, we studied both parameters in Brodmann's area (BA) 9 from the McLean 66 Cohort Collection (Harvard Brain Tissue Resource Center, Belmont, MA). In BA9 of SZ and bipolar disorder patients with psychosis, DNMT1 mRNA and protein expression preferentially increases in layer I, II, and IV interneurons, and this increase is paralleled by a decreased number of GAD67 mRNA-positive neurons. The increase in DNMT1 and the decrease in GAD67-expressing neurons were unrelated to postmortem interval, pH, RNA quality, or to the presence, dose, or duration of antipsychotic (APS) medication, with the exception of a subgroup of SZ patients treated with a combination of valproate and APS in which the expression of DNMT1 failed to change. The DNMT1 increase and the GAD 67 decrease in BA9 interneurons are significant features of SZ and bipolar disorder with psychosis. Interestingly, the DNMT1 increase failed to occur when patients with psychosis received a combination of valproate and APS treatment but not APS monotherapy.

AB - Cortical DNA-methyltransferase 1 (DNMT1) is preferentially expressed in interneurons secreting GABA where it very likely contributes to promoter CpG island hypermethylation, thus causing a down-regulation of promoter functions. To consolidate and expand on previous findings that, in the cortex of schizophrenia (SZ) brains, glutamic acid decarboxylase 67 (GAD67) expression is down-regulated whereas that of DNMT1 is up-regulated, we studied both parameters in Brodmann's area (BA) 9 from the McLean 66 Cohort Collection (Harvard Brain Tissue Resource Center, Belmont, MA). In BA9 of SZ and bipolar disorder patients with psychosis, DNMT1 mRNA and protein expression preferentially increases in layer I, II, and IV interneurons, and this increase is paralleled by a decreased number of GAD67 mRNA-positive neurons. The increase in DNMT1 and the decrease in GAD67-expressing neurons were unrelated to postmortem interval, pH, RNA quality, or to the presence, dose, or duration of antipsychotic (APS) medication, with the exception of a subgroup of SZ patients treated with a combination of valproate and APS in which the expression of DNMT1 failed to change. The DNMT1 increase and the GAD 67 decrease in BA9 interneurons are significant features of SZ and bipolar disorder with psychosis. Interestingly, the DNMT1 increase failed to occur when patients with psychosis received a combination of valproate and APS treatment but not APS monotherapy.

KW - Antipsychotics

KW - Bipolar disorder

KW - Glutamic acid decarboxylase

KW - Schizophrenia

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=13844321733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844321733&partnerID=8YFLogxK

U2 - 10.1073/pnas.0409665102

DO - 10.1073/pnas.0409665102

M3 - Article

VL - 102

SP - 2152

EP - 2157

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -